AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$RKLB

Rocket Lab’s (NASDAQ:RKLB) Q3 2026: strong sales, guides for strong sales next quarter

Rocket Lab (RKLB) reported Q3 2026 revenue of $267.8M, beating estimates by 3.8% and growing 72.7% YoY. Adjusted EPS was $0, a $0.01 beat. Adjusted EBITDA was -$18.05M, with a margin of -6.7%. The company guided Q4 2026 revenue to $280M, above consensus, but EBITDA guidance of -$17M was below estimates. Free cash flow improved to -$23.92M from -$69.44M YoY.

Original reporting
finance.yahoo.com
Published Nov 10, 2026, 2:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 3:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Rocket Lab’s (NASDAQ:RKLB) Q3 2026: strong sales, guides for strong sales next quarter — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$RKLBNeutralMed
01

Why it matters

Earnings beat on revenue but miss on EBITDA guidance may lead to short-term volatility.

02

Market read

First earnings release for Q3 2026; provides fresh data for traders evaluating microcap aerospace stocks.

03

What to watch

Potential upcoming contracts or launch schedule improvements not reflected in guidance.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Rocket Lab reported Q3 2026 results with a 72.7% YoY revenue increase and provided Q4 guidance.

Company-level read

Ticker impact

$RKLBNeutralHigh confidence
Context

Q3 2026 earnings released with revenue beat and guidance above revenue consensus but EBITDA guidance below expectations.

Expected impact

modest downside pressure as market prices in weaker EBITDA guidance

Evidence & confidence

Revenue beat is positive, but guidance miss on EBITDA is a material downside catalyst for a microcap.

Market effects

Sector

Shows pressure on small satellite launch providers as investors scrutinize profitability.

Regional

Limited to US microcap investors; no broad regional effect.

Global

Minimal global impact beyond niche aerospace sector.

Counterpoint

What could challenge this read

Revenue beat could outweigh EBITDA miss, offering a buying opportunity on dip.

Key entities

  • company
    Rocket Lab

    US-listed aerospace launch services provider.

Read at source← All news

StoryRocket Lab posts record Q3 2026 revenue and backlog but misses earnings expectations

Also covered by

6 outlets

Related articles

$RKLBMedAI 8/10

Rocket Lab (RKLB) Q3 2026 Earnings Call Transcript

Rocket Lab (RKLB) reported strong Q3 2026 earnings, with revenue expected to reach nearly $1 billion, up from $35.2 million in 2020. Gross margins improved to 35% GAAP and 40s% non-GAAP. Space Systems signed $688 million in new contracts, a 319% increase from 2025. The company secured record launch contracts, including 18 for the Space Force and 20 for Synspective. Neutron launch was delayed to 2027 due to manufacturing issues.

finance.yahoo.com
$RKLBMed

Rocket Lab stock tumbles as earnings reveal a $3.6 billion twist

Rocket Lab (RKLB) shares fell 7% premarket after reporting a larger-than-expected Q3 loss of 12 cents per share, despite revenue growth and a record order backlog. The company's backlog indicates strong future demand, but investors focused on the earnings miss. Management forecasted a positive Q4 but did not provide specific revenue or backlog details. The stock closed Monday at $58.86 and dropped to $54.99 in early Tuesday trading.

finance.yahoo.com